Madison Area Lyme Support Group

  • About/Contact
  • Articles & Documents
  • Meetings
  • Petitioning the State of Wisconsin
  • Photographs
  • Videos

Archive for the ‘Alzheimer’s’ Category

The Link Between Lyme Disease and Dementia

https://www.bca-clinic.de/en/the-link-between-lyme-disease-and-dementia/

The Link Between Lyme Disease and Dementia

19. September 2019in BCA-clinic

Lyme disease results from infection with the bacterium Borrelia burgdorferi, which is transmitted to humans through the bite of some ticks. Common early symptoms of the illness include fever, headache, fatigue and a characteristic red rash (erythema migrans) at the site of the tick bite.

Early diagnosis is crucial. The sooner Lyme disease is recognised, the easier it is to cure fully with a course of oral antibiotics. As the infection progresses, it may become a lot more persistent. If left untreated for a long time, Lyme disease may enter a chronic phase. The infection can spread throughout the body and cause serious joint, heart and neurological symptoms.

Since the erythema migrans rash is absent in 20–30% of patients and the other symptoms can mimic other illnesses, Lyme disease is often difficult to diagnose. The available laboratory tests are also unreliable in the early stages of the illness. Therefore, doctors have to consider factors such as the patient’s history of tick bites and recent visits to high-risk areas, in addition to any physical signs and symptoms, when making a diagnosis.

Lyme Disease and the Brain

Some common questions about Lyme disease and the brain are ‘Can Lyme disease cause dementia-like symptoms?’ and ‘Does Lyme disease cause memory problems?’ To answer these, let’s take a look at the stats.

Lyme disease leads to profound effects on the brain in about 15% of cases. Some sources suggest that this proportion may be even higher, since thousands of cases are believed to remain undiagnosed every year. A small percentage of patients continue to experience neurological symptoms after receiving timely antibiotic treatment for Lyme disease. This phenomenon is often referred to as ‘post-treatment Lyme disease syndrome’, and its possible cause is a widespread inflammation of the brain.

Neurological Symptoms of Lyme Disease

Chronic Lyme disease develops when the infection remains unrecognised and untreated for a long time. In patients with strong immune systems, the initial symptoms can be very mild and may even go unnoticed. The bacteria can live inside the cells and not cause any problems for several months or even years.

Serious symptoms of chronic Lyme disease tend to first appear when immune function becomes disrupted due to another illness, stress or environmental factors. This is when the bacteria begin to proliferate at a greater pace, and travel to various different tissues and organs.

When Lyme disease becomes chronic and the bacteria spread to the brain, the resulting condition is referred to as neuroborreliosis. Common neurological and psychological symptoms of neuroborreliosis are cognitive decline, memory impairment, mood swings, decreased energy levels, difficulty concentrating, sleep disturbances, disrupted fine motor control and vision changes.

In rare cases, neuropsychiatric Lyme disease can cause paranoia, hallucinations, mania and obsessive-compulsive symptoms. In children, the most common symptoms of neuroborreliosis are headaches, behavioral changes, learning difficulties and sleep disorders.

Patients with chronic Lyme disease often report extreme fatigue. They can sleep for as many as 10 to 12 hours, yet not feel rested after waking up. Increased sensitivity to light and loud sounds can also develop.

Diagnosing Neurological Lyme Disease

In addition to serological testing, patients with suspected neuroborreliosis may benefit from a brain MRI scan. The scan may reveal lesions similar to those caused by multiple sclerosis. Spine lesions have also been observed in some cases. Other diagnostic methods to consider are nerve conduction studies and neurocognitive tests.

Secondary Dementia Due to Lyme Neuroborreliosis

Severe dementia resulting from neuroborreliosis is extremely rare. However, dementia-like syndromes associated with Lyme disease have been reported on occasion.

In a few cases, the condition has seemed to trigger primary dementia, such as Alzheimer’s disease. Persistent chronic Lyme disease is normally treated with several courses of intravenous antibiotics, but it’s unclear whether serious neuropsychiatric symptoms are completely reversible.

Lyme Disease and Dementia/Alzheimer’s Disease

The dementia and other signs of cognitive decline caused by severe neuroborreliosis tend to resemble the symptoms of Alzheimer’s disease. Some research studies have indicated the presence of Borrelia burgdorferi in the brains of Alzheimer’s patients, suggesting a possible link between the two conditions. While Lyme disease can be successfully cured with antibiotics in most cases, the exact causes of Alzheimer’s disease remain unknown, and no effective treatment currently exists.

So how does Lyme affect you in old age? Well, one 2014 study aimed to determine if there was an actual relationship between Lyme and Alzheimer’s. The scientists collected data from the US Centers for Disease Control and Prevention on the incidence of Lyme disease and deaths associated with Alzheimer’s disease. They then analysed the information in search of any significant correlations.

One of the findings of the study was that the 13 states with the highest prevalence of Lyme disease actually had the lowest number of deaths from Alzheimer’s disease. Moreover, the seven states with the highest incidence rates of Alzheimer’s were among the 13 states with the fewest number of Lyme disease cases. Vermont was the only state reporting a high incidence of both conditions. Any other potential associations were found to be statistically insignificant.

The link between Lyme disease and dementia remains unclear, but considering the other possible implications of contracting chronic Lyme, it’s better to be safe than sorry and protect yourself against tick bites altogether.

________________________

For more:  https://madisonarealymesupportgroup.com/2017/06/10/the-coming-pandemic-of-lyme-dementia/

https://madisonarealymesupportgroup.com/2019/05/30/why-lyme-disease-is-causing-a-mental-health-crisis/

https://madisonarealymesupportgroup.com/2019/06/22/dementia-from-illness/

https://madisonarealymesupportgroup.com/2019/03/10/baseballs-tom-seaver-diagnosed-with-dementia/

https://madisonarealymesupportgroup.com/2018/03/25/a-brief-history-of-neuroborreliosis-research-dementia-an-inside-look-at-two-researchers/

https://madisonarealymesupportgroup.com/2016/06/03/borrelia-hiding-in-worms-causing-chronic-brain-diseases/

Category:

Alzheimer's, Lyme, Psychological Aspects

Inflammatory Processes Drive Progression of Alzheimer’s and Other Brain Diseases

https://neurosciencenews.com/alzheimers-inflammation-15235/

Inflammatory processes drive progression of Alzheimer’s and other brain diseases

Neuroscience NewsNEUROSCIENCE NEWSNOVEMBER 20, 2019
Summary: The NLPR3 inflammasome and the inflammatory response it triggers play a critical role in the emergence of tau pathology.Source: DZNE

Inflammation drives the progression of neurodegenerative brain diseases and plays a major role in the accumulation of tau proteins within neurons. An international research team led by the German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn comes to this conclusion in the journal Nature. The findings are based on the analyses of human brain tissue and further lab studies. In the particular case of Alzheimer’s the results reveal a hitherto unknown connection between Amyloid Beta and tau pathology. Furthermore, the results indicate that inflammatory processes represent a potential target for future therapies.

Tau proteins usually stabilize a neuron’s skeleton. However, in Alzheimer’s disease, frontotemporal dementia (FTD), and other “tauopathies” these proteins are chemically altered, they detach from the cytoskeleton and stick together. As a consequence, the cell’s mechanical stability is compromised to such an extent that it dies off. In essence, “tau pathology” gives neurons the deathblow. The current study led by Prof. Michael Heneka, director of the Department of Neurodegenerative Diseases and Gerontopsychiatry at the University of Bonn and a senior researcher at the DZNE, provides new insights into why tau proteins are transformed. As it turns out, inflammatory processes triggered by the brain’s immune system are a driving force.

A Molecular Switch

A particular protein complex, the “NLRP3 inflammasome”, plays a central role for these processes, the researchers report in Nature. Heneka and colleagues already studied this macromolecule, which is located inside the brain’s immune cells, in previous studies. It is a molecular switch that can trigger the release of inflammatory substances. For the current study, the researchers examined tissue samples from the brains of deceased FTD patients, cultured brain cells, and mice that exhibited hallmarks of Alzheimer’s and FTD.

“Our results indicate that the inflammasome and the inflammatory reactions it triggers, play an important role in the emergence of tau pathology”, Heneka said. In particular, the researchers discovered that the inflammasome influences enzymes that induce a “hyperphosphorylation” of tau proteins. This chemical change ultimately causes them to separate from the scaffold of neurons and clump together. “It appears that inflammatory processes mediated by the inflammasome are of central importance for most, if not all, neurodegenerative diseases with tau pathology.”

A Link between Amyloid Beta and Tau

This especially applies to Alzheimer’s disease. Here another molecule comes into play: “amyloid beta” (Amyloid Beta). In Alzheimer’s, this protein also accumulates in the brain. In contrast to tau proteins, this does not happen within the neurons but between them. In addition, deposition of Amyloid Beta starts in early phases of the disease, while aggregation of tau proteins occurs later.

This shows a head with a swirly background

In previous studies, Heneka and colleagues were able to show that the inflammasome can promote the aggregation of Amyloid Beta. Here is where the connection to the recent findings comes in. “Our results support the amyloid cascade hypothesis for the development of Alzheimer’s. According to this hypothesis, deposits of Amyloid Beta ultimately lead to the development of tau pathology and thus to cell death,” said Heneka. “Our current study shows that the inflammasome is the decisive and hitherto missing link in this chain of events, because it bridges the development from Amyloid Beta pathology to tau pathology. It passes the baton, so to speak.” Thus, deposits of Amyloid Beta activate the inflammasome. As a result, formation of further deposits of Amyloid Beta is promoted. On the other hand, chemical changes occur to the tau proteins resulting into their aggregation.

A Possible Starting Point for Therapies

“Inflammatory processes promote the development of Amyloid Beta pathology, and as we have now been able to show, of tau pathology as well. Thus, the inflammasome plays a key role in Alzheimer’s and other brain diseases,” said Heneka, who is involved in the Bonn-based “ImmunoSensation” cluster of excellence and who also teaches at the University of Massachusetts Medical School. With these findings, the neuroscientist sees opportunities for new treatment methods. “The idea of influencing tau pathology is obvious. Future drugs could tackle exactly this aspect by modulating the immune response. With the development of tau pathology, mental abilities decline more and more. Therefore, if tau pathology could be contained, this would be an important step towards a better therapy.”

ABOUT THIS NEUROSCIENCE RESEARCH ARTICLE

Source:
DZNE
Media Contacts:
Marcus Neitzert – DZNE
Image Source:
The image is in the public domain.

Original Research: Closed access
“NLRP3 inflammasome activation drives tau pathology”. Christina Ising et al.
Nature doi:10.1038/s41586-019-1769-z.

Abstract

NLRP3 inflammasome activation drives tau pathology

Alzheimer’s disease is characterized by the accumulation of amyloid-beta in plaques, aggregation of hyperphosphorylated tau in neurofibrillary tangles and neuroinflammation, together resulting in neurodegeneration and cognitive decline1. The NLRP3 inflammasome assembles inside of microglia on activation, leading to increased cleavage and activity of caspase-1 and downstream interleukin-1β release2. Although the NLRP3 inflammasome has been shown to be essential for the development and progression of amyloid-beta pathology in mice3, the precise effect on tau pathology remains unknown. Here we show that loss of NLRP3 inflammasome function reduced tau hyperphosphorylation and aggregation by regulating tau kinases and phosphatases. Tau activated the NLRP3 inflammasome and intracerebral injection of fibrillar amyloid-beta-containing brain homogenates induced tau pathology in an NLRP3-dependent manner. These data identify an important role of microglia and NLRP3 inflammasome activation in the pathogenesis of tauopathies and support the amyloid-cascade hypothesis in Alzheimer’s disease, demonstrating that neurofibrillary tangles develop downstream of amyloid-beta-induced microglial activation.

_________________

For more:  https://madisonarealymesupportgroup.com/2019/07/22/does-alzheimers-disease-stem-from-infection-scientists-debate-one-company-targets-gingivitis-bacterium-to-slow-alzheimers-progression/

https://madisonarealymesupportgroup.com/2018/09/11/its-time-to-find-the-alzheimers-germ/

For more on the potential connection between Alzheimer’s and tick borne illness:

https://madisonarealymesupportgroup.com/2016/06/09/alzheimers-byproduct-of-infection/ (Link to Kris Kristofferson’s case. Lyme treatment turned the Alzheimer’s completely around)

https://madisonarealymesupportgroup.com/2017/01/18/a-bug-for-alzheimers/

https://madisonarealymesupportgroup.com/2018/07/28/herpes-viruses-implicated-in-alzheimers-disease/

https://madisonarealymesupportgroup.com/2016/06/03/borrelia-hiding-in-worms-causing-chronic-brain-diseases/

https://madisonarealymesupportgroup.com/2016/08/09/dr-paul-duray-research-fellowship-foundation-some-great-research-being-done-on-lyme-disease/

https://madisonarealymesupportgroup.com/2018/03/25/a-brief-history-of-neuroborreliosis-research-dementia-an-inside-look-at-two-researchers/

https://madisonarealymesupportgroup.com/2017/10/14/lost-link-als-lyme/

https://madisonarealymesupportgroup.com/2017/06/10/the-coming-pandemic-of-lyme-dementia/

 

 

Category:

Alzheimer's, Inflammation, Lyme, Uncategorized

Finding Link Between Infection & Alzheimer’s Disease Could Be Worth $ 1 Million

https://www.idse.net/Policy–Public-Health/Article/10-19/Finding-Link-Between-Infection-and-Alzheimer-s-Disease-Could-Be-Worth-1-Million/56312  Full article here

Finding Link Between Infection and Alzheimer’s Disease Could Be Worth $1 Million

OCTOBER 15, 2019

By Tom Rosenthal

WASHINGTON—If you can present persuasive evidence that a particular microbe causes Alzheimer’s disease, there’s a $1 million prize waiting for you.

“This is an award for achievement; it is not a grant,” said Leslie N. Norins, MD, PhD, FIDSA, the founder and CEO of Alzheimer’s Germ Quest, Inc. (ALZgerm.org). The nonprofit group is funding the award to encourage more intensive research on the possibility that microorganisms are the root cause of the incurable disease afflicting 47 million people worldwide, including 5.6 million Americans aged 65 years and older.

“I’ve closely reviewed the scientific literature and personally believe it’s clear that one germ, possibly not yet discovered, is the root cause of most Alzheimer’s disease,” Dr. Norins said. “But we’ll see what researchers find out.”

_______________

**Comment**

I posted on this a year ago when Leslie Norins, Ph.D. wrote this fantastic paper:  https://madisonarealymesupportgroup.com/2018/09/11/its-time-to-find-the-alzheimers-germ/

Alzheimer’s has had a Cabal similarly to Lyme in that research has been hijacked by a group of individuals with blinders on.  According to Norins, the 2017 Alzheimer’s Association had a conference in London where researchers from 70 countries could share progress.  A keyword index of the presentations showed the largest entries, 110, were for amyloid/APP.The next most common item was tau, the tangled protein, with 85 entries. Inflammation—the body’s reaction to something—had 45 mentions.  Presentations of germ importance had only single digit presence: prion proteins (8 entries), infectious disease (4 entries), bacteria (1 entry). Virus was not even listed as a keyword.

Yet numerous researchers have doggedly fought against the myopic focus and have found spirochetes in the brains of Alzheimer’s patients:   https://madisonarealymesupportgroup.com/2016/06/09/alzheimers-byproduct-of-infection/, and Kris Kristofferson was diagnosed with Alzheimer’s but actually had Lyme disease:  https://madisonarealymesupportgroup.com/2017/01/04/aluminum-alzheimers-ld/

https://madisonarealymesupportgroup.com/2017/01/18/a-bug-for-alzheimers/

https://madisonarealymesupportgroup.com/2016/06/09/alzheimers-byproduct-of-infection/

https://madisonarealymesupportgroup.com/2016/11/17/antibiotics-and-alzheimers/

https://madisonarealymesupportgroup.com/2016/06/03/borrelia-hiding-in-worms-causing-chronic-brain-diseases/

https://madisonarealymesupportgroup.com/2018/03/25/a-brief-history-of-neuroborreliosis-research-dementia-an-inside-look-at-two-researchers/  Fantastic read by microbiologist Tom Grier.

https://madisonarealymesupportgroup.com/2017/06/10/the-coming-pandemic-of-lyme-dementia/

https://madisonarealymesupportgroup.com/2016/11/17/alzheimers-lyme/

https://madisonarealymesupportgroup.com/2018/07/28/herpes-viruses-implicated-in-alzheimers-disease/

Category:

Alzheimer's, Lyme

New Alzheimer’s Blood Test 94% Accurate

https://www.medscape.com/viewarticle/916372

New Alzheimer’s Blood Test 94% Accurate

Megan Brooks

August 02, 2019

A new blood test to detect brain changes emblematic of early Alzheimer’s disease (AD) has moved one step closer to reality and could be a “game changer” for the field.

Researchers found that measuring the ratio of β-amyloid (Aβ) 42 and Aβ40 in blood using a high-precision assay is 94% accurate in diagnosing brain amyloidosis, using amyloid PET or CSF phosphorylated (p-tau) 181/Aβ42 as reference standards.

“Right now we screen people for clinical trials with brain scans, which is time-consuming and expensive, and enrolling participants takes years,” senior investigator Randall J. Bateman, MD, professor of neurology, Washington University School of Medicine in St. Louis, said in a statement.

“But with a blood test, we could potentially screen thousands of people a month. That means we can more efficiently enroll participants in clinical trials, which will help us find treatments faster, and could have an enormous impact on the cost of the disease as well as the human suffering that goes with it,” he added.

The study was published online August 1 in Neurology.

Easy Screening Tool

Using an immunoprecipitation and liquid chromatography–mass spectrometry assay, the researchers measured Aβ42/Aβ40 in plasma and CSF samples from 158 older, mostly cognitively normal individuals (94% with Clinical Dementia Rate [CDR] = 0) that were collected within 18 months of an amyloid PET scan.

Plasma Aβ42/Aβ40 correlated highly with amyloid PET status (receiver operating characteristic area under the curve [AUC], 0.88; 95% confidence interval [CI], 0.82 – 0.93) and CSF p-tau181/Aβ42 (AUC, 0.85; 95% CI, 0.79 – 0.92), the researchers report.

The combination of plasma Aβ42/Aβ40, age, and apolipoprotein (APOE) ε4 status had “very high” correlation with amyloid PET (AUC, 0.94; 95% CI, 0.90 – 0.97), “suggesting that plasma Aβ42/Aβ40 may be used as a screening tool for those at risk of AD dementia,” the researchers write.

In addition, individuals with a positive plasma Aβ42/Aβ40 but negative amyloid PET scan have a 15-fold higher risk of converting to amyloid PET-positive (P = .01).

“The sensitivity of the plasma Aβ42/Aβ40 assay to amyloid PET-negative individuals who convert to amyloid PET-positive suggests that plasma Aβ42/Aβ40 becomes positive earlier than the established amyloid PET threshold used for this study,” Bateman and colleagues note in their report.

“Therefore, a positive plasma Aβ42/Aβ40 with a negative amyloid PET scan may represent early amyloidosis rather than a false-positive result in some individuals,” they add.

As reported by Medscape Medical News, the study builds on earlier work by the same researchers.

________________

For more: https://madisonarealymesupportgroup.com/2019/07/10/lyme-alzheimers-enbrel-new-potential-treatment/

https://madisonarealymesupportgroup.com/2019/04/09/the-diagnosis-is-alzheimers-but-thats-probably-not-the-only-problem/

https://madisonarealymesupportgroup.com/2019/03/09/researchers-identify-herpes-1-chlamydia-pneumoniae-several-types-of-spirochaete-as-major-causes-of-alzheimers/

https://madisonarealymesupportgroup.com/2017/01/18/a-bug-for-alzheimers/

https://madisonarealymesupportgroup.com/2016/06/09/alzheimers-byproduct-of-infection/

https://madisonarealymesupportgroup.com/2016/11/17/antibiotics-and-alzheimers/

https://madisonarealymesupportgroup.com/2016/06/03/borrelia-hiding-in-worms-causing-chronic-brain-diseases/

https://madisonarealymesupportgroup.com/2018/03/25/a-brief-history-of-neuroborreliosis-research-dementia-an-inside-look-at-two researchers/https://madisonarealymesupportgroup.com/2016/11/17/alzheimers-lyme

Category:

Alzheimer's, Testing

The Dementia Letters Project

https://samaritanministries.org/blog/member-spotlight-kathryne-fassbender-of-the-dementia-letters-project?

Kathryne Fassbender of the Dementia Letters Project

Brittany Klaus Jul 26, 2019

fassbender

Kathryn Fassbender

A passion for serving the elderly has led Kathryne Fassbender to start a dialogue about dementia to help both those living with the condition and their care partners.

At DementiaLettersProject.com, the Wisconsin resident and certified dementia communication specialist is creating the dialogue with input from care partners, family members, medical staff, and, most importantly, the individuals living with dementia.

The letters, she says, “can be (written) to dementia, to their future self who they fear might have dementia, or to a loved one with dementia. It can be expressing those fears, sharing their story of dementia, or sharing the gifts of dementia.”

Dementia is, according to CaringKind.com, the loss of cognitive functioning—thinking, remembering, and reasoning—and behavioral abilities to an extent that it interferes with a person’s daily life and activities.

“Dementia is an umbrella term that includes several different types of dementia with their own unique characteristics,” she says. “While dementia can take much away from one’s life, it does not take away their own experiences, joy, or spirit.”

Kathryne’s service to those affected by dementia started on a volunteer basis through middle-school service projects. She focused on aging.

“I was drawn into helping those with dementia first by finding that I connected well with individuals with dementia,” she says. By seeing the great misunderstanding her classmates had about the disease, she felt an even greater pull to work with those living with dementia.

Then in 2005 her grandmother was diagnosed with vascular dementia.

“Around that time not only was I experiencing dementia personally, but I was seeing how professionally it might evolve and become a professional vocation,” Kathryne says.

There is great healing through storytelling, and letter writing is a beautiful and easy form of storytelling.  Kathryne Fassbender

She earned her undergraduate degree in art therapy at Edgewood College in Wisconsin and interned at an adult day program that focused on dementia. From there she has gone on to work as a life-enrichment specialist and now leads dementia training workshops, works as a family consultant, speaks at conferences, and, in 2017, formed the Dementia Letters Project. Besides earning her CDCS last year, she also has earned a certificate in arts and health therapy.

Kathryne attributes the start of the Dementia Letters Project to “a couple of things colliding.”

She says she was beginning to discover people with dementia like Brian LeBlanc and Kate Swaffer who write blogs and are “calling out for people to recognize them and recognize their story and that their story is not what all medical professionals are telling us.”

“It’s not all doom and gloom, it’s not all memory loss and becoming medicalized,” Kathryne says.

She also noted family members and staff at a care community saying that they had fears about dementia but were afraid to share them and needed a platform where they could do that.

The Dementia Letters Project encourages others to share their story of dementia by writing letters for submission to DementiaLettersProject.com or for sharing within their family.

“These letters can be written to dementia itself, to the individual’s future self, or to a loved one with dementia,” she says. “It can express fears and joys about their personal story of dementia.”

Kathryne emphasizes that these letters are not all about fears, such as worry about when a loved one might the name of their children. It is also about those moments spent together that might not have happened without dementia. The goal of the Dementia Letters Project is to build a community that is “wealthy in hope and connection” for someone with dementia as well as friends, family, and care partners. The website also includes links to resources and Kathryne’s blog.

“My hope with the Dementia Letters Project is to allow those who may not want to be a visible voice via platforms like a blog, book, or speaking engagements to still be able to share their voice,” she says. “I also want families and community members to help us deepen the reality of dementia, to share their fears, their joys, their experiences. There is great healing through storytelling, and letter writing is a beautiful and easy form of storytelling.”

Kathryne says that dementia is more than what we’re reading in news articles or seeing on TV specials. It’s not only despondency; there is also joy, hope, and light—and conveying that to families and care communities has been Kathryne’s mission over the past two years.

“We need to be visionaries and servants of the Lord to individuals with dementia, despite our own fears and misunderstandings,” Kathryne says. “We have a duty to grow in knowledge about dementia and aging so that we can better minister to others.”

At the same time, Kathryne says we must not “medicalize” someone with dementia; we cannot forget to include their faith with the sudden checklist that appears with the diagnosis—making sure they eat, sleep, are dressed, and take prescribed medication. She encourages family members, friends, and care partners to ask themselves how they can make sure that their loved ones are still practicing their faith. Encouraging someone with dementia in their faith can be as simple as singing hymns with them or saying the Lord’s Prayer together—things that are ingrained in them, firmly rooted in their emotional memory.

To someone who is struggling with dementia, Kathryne says, “Your value never decreases in God’s eyes, and your ability to grow in faith never ceases.”

Kathryne spreads awareness and builds bridges by speaking at conferences. She realized there was a need for people who aren’t medical professionals but who are working with someone living with dementia to “enter the public speaking round.” She describes the medical community as being very “siloed,” especially when it comes to aging and dementia. Doctors and nurses will be in one silo and think they’re right, while academic researchers will be in their separate silo, and then those who take a more creative approach to dementia care will be in their silo.

“We need more bridges,” Kathryne says, “because we’re not really going to break the barrier of where we are right now with knowledge of dementia until we start communicating with each other and learn how to put our language into another person’s language, and then be able to share that with families. That’s where I am—trying to figure out that spot, that in-between spot, that can put medical research and creative aging language into layman’s terms.”

_________________

**Comment**

Please remember that both dementia and Alzheimer’s can be caused by Lyme/MSIDS. Deal with the infections and you can often gain cognitive ability back:  https://madisonarealymesupportgroup.com/2018/10/03/chronology-of-research-on-lyme-disease-dementia-alzheimers-parkinsons-autism/

https://madisonarealymesupportgroup.com/2019/06/22/dementia-from-illness/

https://madisonarealymesupportgroup.com/2019/04/27/breaking-news-definition-of-lyme-disease-dementia-has-improved/

https://madisonarealymesupportgroup.com/2018/03/25/a-brief-history-of-neuroborreliosis-research-dementia-an-inside-look-at-two-researchers/

https://madisonarealymesupportgroup.com/2017/06/10/the-coming-pandemic-of-lyme-dementia/

https://madisonarealymesupportgroup.com/2019/04/09/the-diagnosis-is-alzheimers-but-thats-probably-not-the-only-problem/

https://madisonarealymesupportgroup.com/2017/01/04/aluminum-alzheimers-ld/  Within this article, Dr. Marc Siegel explains on ‘Fox & Friends’ how Kris Kristofferson was diagnosed with Alzheimer’s but actually had Lyme Disease.  (Warning:  the news reporter propagates a myth that “One antibiotic,” prophylactically will cure LD if used early.)

Category:

Activism, Alzheimer's, Psychological Aspects

Search

Archives

Lyme Non-Profits

  • Wisconsin Lyme Network Facebook

Lyme Resources

  • Affordable Blood Draws/injections in Wisconsin
  • Blood Draws in Madison
  • Columbia Specimen Bank 646-774-7503
  • Dental Care For Children With Autism
  • Find a Lyme Support Group
  • IGeneX, Inc. (lab testing)
  • ILADS (International Lyme And Associated Diseases Society)
  • Learn about Lyme
  • Lyme Bio Bank (NDRI & Bay Area Lyme Foundation)
  • Lyme Curriculum & Educational Activities
  • Lyme Disease Association
  • Lyme Info
  • Lyme Resource Zip File
  • Lyme-Symptoms
  • Lymedisease.org (Formally CALDA)
  • LymeLight Foundation
  • National Suicide Hotline
  • On-line Mental Health Therapy
  • SE Wisconsin Support Group
  • Substance Abuse Rehab Centers in Wisconsin
  • Substance Misuse Support
  • Suicide & Social Media
  • Tick borne disease education
  • Tick Borne Disease Prevention: Stuff for Kids
  • Tick Prevention
  • Tick-Borne Disease Alliance
  • TRUTHCURES
  • What is Lyme

Online Support Groups

  • Lyme Support Group of Southeast Wisconsin (Facebook)
  • Military Lyme Info
  • Military Lyme Support (Facebook)
  • Parents Whose Children Have Lyme/MSIDS
  • Wisconsin/Illinios Lyme (Facebook)

Visitors

  • 8,078,102

Top Posts & Pages

  • Ivermectin's Accidental Breakthrough: Parkinson's & Alzheimer's
  • Proof That the Pandemic Was Planned & With Purpose
  • Ahead of the Curve Interview With Dr. Alan McDonald
  • Lost Link - ALS & Lyme
  • The Three Bs - Borrelia, What, and What? Co-infections & Chronic Illness
  • Persistent Infection, Molecular Mimicry, and the Future of Chronic Lyme
  • Bill Gates' Former Doctor Says Billionaire 'Refused to Vaccinate His Children'
  • Biofilms: What Are They? How Do They Impact Chronic Infections?
  • Calling All Doctors Please - Become Educated Regarding Tick-Borne Illness - Here's How
  • CDC Now Lists Lyme As Infection That Can Cause Chronic Symptoms - Don't Expect Much From This

Categories

  • Activism
  • Adrenals
  • Allodynia
  • Alpha Gal Meat Allergy
  • Alzheimer's
  • Anaplasmosis
  • Anaplasmosis Treatment
  • Autism
  • Babesia
  • Babesia Treatment
  • Bartonella
  • Bartonella Treatment
  • Biofilm
  • Borrelia Miyamotoi (Relapsing Fever Group)
  • C-diff
  • Cancer
  • Candida
  • Chiropractic Care for MSIDS
  • Climate
  • Clinic
  • Corrections
  • Dentistry
  • Detoxing
  • diet and nutrition
  • Disability
  • Educational handouts
  • Ehrlichiosis
  • Ehrlichiosis Treatment
  • EMF
  • Eye Issues
  • Genetic Mutations
  • Gut Health
  • Hearing Loss
  • Heart Issues
  • Hemp Oil
  • Herbs
  • Hormones
  • Hyperthermia
  • Inflammation
  • Interstitial Cystitis
  • Lyme
  • Lyme Disease Treatment
  • Lyme Vaccine
  • Malaria
  • Marijuana
  • Mast Cell Activation Syndrome (MCAS)
  • Meetings
  • Mold
  • Morgellons
  • mosquitoes
  • Mycoplasma
  • Mycoplasma Treatment
  • Pain Management
  • PANS
  • Parasite Treatment
  • Parasites
  • Pregnancy
  • Prevention
  • Psychological Aspects
  • Q Fever
  • research
  • Rickettsia
  • Rocky Mountain Spotted Fever
  • Sleep
  • Supplements
  • Support Group Presentations
  • Syphilis
  • Testing
  • thyroid
  • Tickborne Relapsing Fever
  • Ticks
  • Toxoplasmosis
  • Transmission
  • Treatment
  • Tularemia
  • Uncategorized
  • vaccines
  • Viruses
  • Zika

Older Posts

Newer Posts

Madison Area Lyme Support Group
  • Subscribe Subscribed
    • Madison Area Lyme Support Group
    • Join 684 other subscribers
    • Already have a WordPress.com account? Log in now.
    • Madison Area Lyme Support Group
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar
 

Loading Comments...